Difference between revisions of "Part:BBa K3606003"
Line 5: | Line 5: | ||
This part produces an antibiotic originated from Escherichia coli that targets a bacterial topoisomerase, DNA gyrase. | This part produces an antibiotic originated from Escherichia coli that targets a bacterial topoisomerase, DNA gyrase. | ||
− | <h2> | + | <h2>Background:</h2> |
+ | Here, we tried to improve the former antimicrobial peptide(mccb17) expressing system of 2019 Fudan[[BBa_K3245010]]. By dividing into the peptide expressing parts and the immunity parts, we wanted to firstly test whether the polycistron could work properly and separately, then | ||
+ | manipulate their expression level with more efficiency. | ||
− | This part is an antibiotic coding gene cluster with leader peptide and proteins for maturation | + | <h2>Design:</h2> |
+ | This part is an antibiotic coding gene cluster with leader peptide and proteins for its maturation. | ||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
− | + | <h2>Usage and Biology:</h2> | |
+ | We introduced it to our improved antibiotic expressing system to inhibit the growth of other bacteria in human intestine so as to enhance Nissle's competitiveness, as well as to reduce risk of illness caused by some opportunistic pathogens. | ||
<!-- --> | <!-- --> | ||
<span class='h3bb'></span> | <span class='h3bb'></span> | ||
<partinfo>BBa_K3606003 SequenceAndFeatures</partinfo> | <partinfo>BBa_K3606003 SequenceAndFeatures</partinfo> | ||
+ | <h2>Results:</h2> | ||
+ | We constructed the plasmid and successfully expressed the mcbABCD, here is the electrophoresis map. | ||
+ | 图 | ||
+ | <h2>Further Application:</h2> | ||
+ | For futher application, this part is provided as an antimicrobial peptide(mccb17) expressing example and are effective for a wide range of microbes. | ||
<!-- Uncomment this to enable Functional Parameter display | <!-- Uncomment this to enable Functional Parameter display |
Revision as of 06:56, 25 October 2020
mcbABCD
This part produces an antibiotic originated from Escherichia coli that targets a bacterial topoisomerase, DNA gyrase.
Background:
Here, we tried to improve the former antimicrobial peptide(mccb17) expressing system of 2019 FudanBBa_K3245010. By dividing into the peptide expressing parts and the immunity parts, we wanted to firstly test whether the polycistron could work properly and separately, then manipulate their expression level with more efficiency.
Design:
This part is an antibiotic coding gene cluster with leader peptide and proteins for its maturation.
- 10INCOMPATIBLE WITH RFC[10]Illegal PstI site found at 2297
Illegal PstI site found at 2330 - 12INCOMPATIBLE WITH RFC[12]Illegal PstI site found at 2297
Illegal PstI site found at 2330 - 21COMPATIBLE WITH RFC[21]
- 23INCOMPATIBLE WITH RFC[23]Illegal PstI site found at 2297
Illegal PstI site found at 2330 - 25INCOMPATIBLE WITH RFC[25]Illegal PstI site found at 2297
Illegal PstI site found at 2330
Illegal NgoMIV site found at 1959
Illegal AgeI site found at 2131 - 1000COMPATIBLE WITH RFC[1000]
Results:
We constructed the plasmid and successfully expressed the mcbABCD, here is the electrophoresis map. 图
Further Application:
For futher application, this part is provided as an antimicrobial peptide(mccb17) expressing example and are effective for a wide range of microbes.
Reference
Collin F, Maxwell A. The Microbial Toxin Microcin B17: Prospects for the Development of New Antibacterial Agents. J Mol Biol. 2019;431(18):3400–3426. doi:10.1016/j.jmb.2019.05.050
S. Duquesne, D. Destoumieux-Garzón, J. Peduzzi, S. Rebuffat. Microcins, gene-encoded antibacterial peptides from enterobacteria
Sassone-Corsi M, Nuccio SP, Liu H, Hernandez D, Vu CT, Takahashi AA, Edwards RA, Raffatellu M. Microcins mediate competition among Enterobacteriaceae in the inflamed gut. Nature. 2016 Dec 8;540(7632):280-283.